June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Can the Inner Nuclear Layer Thickness Help Detect Progression in Advanced Glaucoma?
Author Affiliations & Notes
  • Eitan Shemuelian
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
  • Gadi Wollstein
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
    Department of Biomedical Engineering, New York University Tandon School of Engineering, Brooklyn, New York, United States
  • Maria de los Angeles Ramos Cadena
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
  • Zeinab Ghassabi
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
  • TingFang Lee
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
    Department of Population Health, NYU Langone Health, New York, New York, United States
  • Jiyuan Hu
    Department of Population Health, NYU Langone Health, New York, New York, United States
    Department of Environmental Science, NYU Langone Health, New York, New York, United States
  • Hiroshi Ishikawa
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
    Departments of Ophthalmology, Medical Informatics, and Clinical Epidemiology, Oregon Health & Science University Casey Eye Institute, Portland, Oregon, United States
  • Joel S Schuman
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
    Department of Biomedical Engineering, New York University Tandon School of Engineering, Brooklyn, New York, United States
  • Fabio Lavinsky
    School of Medicine, Universidade do Vale do Rio dos Sinos, Sao Leopoldo, RS, Brazil
  • Footnotes
    Commercial Relationships   Eitan Shemuelian None; Gadi Wollstein None; Maria de los Angeles Ramos Cadena None; Zeinab Ghassabi None; TingFang Lee None; Jiyuan Hu None; Hiroshi Ishikawa None; Joel Schuman Zeiss, Code P (Patent); Fabio Lavinsky None
  • Footnotes
    Support  NIH R01-EY013178; P30EY013079; unrestricted grant from Research to Prevent Blindness (New York, NY)
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 4261. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Eitan Shemuelian, Gadi Wollstein, Maria de los Angeles Ramos Cadena, Zeinab Ghassabi, TingFang Lee, Jiyuan Hu, Hiroshi Ishikawa, Joel S Schuman, Fabio Lavinsky; Can the Inner Nuclear Layer Thickness Help Detect Progression in Advanced Glaucoma?. Invest. Ophthalmol. Vis. Sci. 2022;63(7):4261.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The ability to detect progression in eyes with advanced glaucoma is challenging because of known limitations of commonly used structural and functional parameters reaching their minimal measurable limit (floor effect) or increased measurement variability. We examined the ability of inner nuclear layer (INL) thickness measurements to demonstrate change longitudinally in eyes with early and advanced severity glaucoma.

Methods : Subjects with glaucoma and ≥4 visits were included in the study. Subjects in the “Early/Moderate” group (EG) had average circumpapillary retinal nerve fiber layer (cRNFL) thicknesses ≥60µm and subjects in the “Advanced” group (AG) had average cRNFL thicknesses ≤60µm. All subjects had comprehensive ophthalmic examination, Humphrey visual field (Zeiss, Dublin, CA) testing, and spectral-domain OCT (Cirrus HD-OCT; Zeiss) optic nerve head (ONH) and macula scans. Segmentation of the INL was performed using the Iowa Reference Algorithms (Retinal Image Analysis Lab, Iowa Institute for Biomedical Imaging, Iowa City, IA) and segmentation errors were manually corrected by a trained grader. Overall INL thickness along with the superior and inferior hemifields were used for analysis. Rates of progression were estimated from longitudinal OCT and visual field (VF) data using mixed effects models adjusting for baseline age, follow-up duration, and signal strength at each visit.

Results : 23 eyes (23 subjects), 12 with EG and 11 with AG, were included in the study. At baseline, a statistically significant difference between groups was detected in MD, cRNFL, and GCIPL thicknesses (Table 1). In EG eyes, the rate of change was significantly different than a zero slope for cRNFL thickness, C:D ratio, and GCIPL thickness (Table 2). Inferior INL thickness was the only INL parameter showing significant rate of change. However, in the advanced group, all parameters (including both global and sectoral INL thicknesses) showed significant rate of change except for the cRNFL.

Conclusions : Longitudinal measurements of INL thickness may be useful for following disease progression in subjects with advanced-stage glaucoma where cRNFL thickness is no longer useful.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×